NCT03700723View on ClinicalTrials.gov

Comparison of the Efficacy & Safety of Resusix With FP24 in Patients With Acquired Coagulopathy

PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

December 14, 2018

Primary Completion Date

April 15, 2020

Study Completion Date

April 15, 2020

Conditions
Coagulopathy
Interventions
BIOLOGICAL

Resusix

spray-dried solvent/detergent treated plasma (blood product)

BIOLOGICAL

FP24 (Frozen Plasma)

plasma frozen within 24 hours of phlebotomy

Trial Locations (3)

28203

Carolinas Medical Center, Charlotte

63110

Washington University St. Louis, St Louis

85721

University of Arizona, Tucson

Sponsors

Lead Sponsor

Entegrion, Inc.
All Listed Sponsors
lead

Entegrion, Inc.

INDUSTRY